Chapin Davis Inc. raised its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 33.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,050 shares of the company’s stock after buying an additional 5,500 shares during the quarter. Chapin Davis Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $361,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of BMEZ. B. Riley Wealth Advisors Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 4.8% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock worth $250,000 after buying an additional 796 shares during the period. Pine Valley Investments Ltd Liability Co increased its stake in shares of BlackRock Health Sciences Term Trust by 6.7% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock valued at $192,000 after purchasing an additional 822 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 24.1% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock valued at $70,000 after purchasing an additional 930 shares during the last quarter. LPL Financial LLC boosted its holdings in BlackRock Health Sciences Term Trust by 0.5% in the third quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after acquiring an additional 1,231 shares in the last quarter. Finally, Oppenheimer & Co. Inc. boosted its stake in BlackRock Health Sciences Term Trust by 2.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock worth $1,124,000 after purchasing an additional 1,536 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Performance
NYSE:BMEZ opened at 15.40 on Tuesday. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The firm has a 50-day simple moving average of 15.12 and a two-hundred day simple moving average of 15.39.
BlackRock Health Sciences Term Trust Increases Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Trading Halts Explained
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to invest in marijuana stocks in 7 steps
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Invest in the FAANG Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.